Skip to content

KLRS KLRS Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

Eli Lilly logo
Eli LillyLLY
Merck & Co. logo
Merck & Co.MRK
Amgen logo
AmgenAMGN
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
EyePoint, Inc.
 logo
EyePoint, Inc. EYPT
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD

Other financials

Income statement

See full
Operating income-$11.8M-14.3%
Net income-$10.9M-6.5%
EPS (diluted)-$0.46+81.7%

Balance sheet

See full
Cash & equivalents$34.4M-65.9%
Total debt$1.4M
Total equity$68.6M+7.3%
Total assets$109.8M+6.5%

Cash flow

See full
Operating cash flow-$11.6M-55.6%
CapEx$17.0K
Free cash flow-$7.1M

Valuation

See full
Market cap$96.83M+136%
Enterprise value$63.82M

Returns & leverage

See full
Return on equity-66.6%
Debt / equity
Current ratio12.2×-2.1×

Where this comes from

Reported directly by KLRS in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: KLRS’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about KLRS's software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KLRS's software and technology licenses, net?
KLRS (KLRS) reported software and technology licenses, net of $1.75M in Q1 2026.
How has KLRS's software and technology licenses, net changed year-over-year?
KLRS's software and technology licenses, net increased by 327.6% year-over-year, from $410K to $1.75M.
What is the long-term trend for KLRS's software and technology licenses, net?
Over 4 years (2021 to 2025), KLRS's software and technology licenses, net has grown at a -3.6% compound annual growth rate (CAGR), from $1.1M to $953K.